Recent Searches
 
 
 
Home |  Viral Packaging | Trans-Lentiviral™ Packaging Sy

Trans-Lentiviral Packaging


 Figure 1:  Packaging with the Trans-Lentiviral System
 
Purchasing Information
Cat # Description Literature ACA COM Buy
TLP4614
Trans-Lentiviral pGIPZ Packaging System - 10rxn   $890.00 $890.00
Search:
(only clones from TLP4614)
TLP4615 Trans-Lentiviral pGIPZ Packaging System with HEK293T cells - 10 rxn   $1,020.00 $1,020.00
Search:
(only clones from TLP4615)
TLP4691
Trans-Lentiviral pGIPZ Bulk Packaging - 50 rxn   $1,967.00 $1,967.00
Search:
(only clones from TLP4691)
TLP4692 Trans-Lentiviral pGIPZ Bulk Packaging - 100 rxn   $2,967.00 $2,967.00
Search:
(only clones from TLP4692)
TLP4616
Trans-Lentiviral pLEX Packaging System - 10 rxn   $890.00 $890.00
Search:
(only clones from TLP4616)
TLP4617 Trans-Lentiviral pLEX Packaging System with HEK293T cells - 10 rxn   $1,020.00 $1,020.00
Search:
(only clones from TLP4617)
TLP4693
Trans-Lentiviral pLEX Bulk Packaging 50 rxn   $1,967.00 $1,967.00
Search:
(only clones from TLP4693)
TLP4694 Trans-Lentiviral pLEX Bulk Packaging 100 rxn   $2,967.00 $2,967.00
Search:
(only clones from TLP4694)
HCL4517
HEK293T cell line   $265.00 $265.00
Search:
(only clones from HCL4517)
search:Search add to cart:Cart product kit: Kit product insert:Literature datafile:Data File

Trans-Lentiviral™ Packaging System
NEWEST Generation Packaging System

The Trans-Lentiviral Packaging System is the most effective strategy for efficiently expressing your gene or shRNA of interest.  Co-transfection of the plasmids into the packaging cell line, TLA-HEK293T™, allows efficient production of lentiviral supernatant which can then be transduced and expressed in a wider range of cell types than traditional retroviral systems (Figure 1).

Highly Efficient Expression

  • CONSISTENT TITERS: 1 - 5 x 106 transducing units (TU) per ml (unconcentrated) are commonly achieved.
  • BROAD TROPISM: Effectively transduce most mammalian cell lines including primary and non-dividing cells.

Multi-Generational Flexibility

The only commercially available packaging system that allows you to effectively package both second and third generation lentiviral vectors.

Unsurpassed Biosafety

Open Bisoystems engineered this new generation Trans-Lentiviral Packaging System to be effective and safe.  The packaging system includes a number of features designed to enhance its biosafety and to prevent the generation of replication-competent viral particles.

  • SPLIT GAG-POL COMPONENTS: The reverse transcriptase (RT) and integrase (IN) proteins are provided in trans producing a class of vectors that contain split gag-pol components on separate vectors.
  • FIVE SEPARATE PLASMIDS: Genes encoding the structural and other components required for packaging the viral genome are separated onto five plasmids minimizing the threat of recombinant replication competent virus production.
  • REPLICATION-INCOMPETENT: None of the structural genes are actually present in the packaged viral genome, therefore no new replication-competent virus can be produced.

Additional information on the packaging mix plasmids and their safety features can be found at the Trans-Lentiviral Biosafety.

System Components

The packaging system contains all of the necessary components for up to 10 packaging events and can be ordered with (system 2) or without (system 1) the packaging cell line, TLA-HEK293T.  Or choose from two bulk packaging systems that contain a larger volume of the packaging mix and transfection reagent.  The two bulk packaging systems have a sufficient quantity to perform 50 or 100 packaging events.  The complete system includes the following components:

Component*
Description
Function
Cell Line* 
TLA-HEK293T™
Allows production of the lentivirus following co-transfection of the transfer plasmid and the packaging plasmids in the packaging mix
Packaging Mix
Optimized mixture of the five packaging plasmids:  pTLA1-Pak, pTLA1-Enz, pTLA1-Env, pTLA1-Rev and pTLA1-TOFF
Supply the helper functions as well as structural and enzymatic proteins in trans required to produce the lentivirus
Transfection Reagent*
Arrest-In™  (shRNA)

Express-In™ (ORF)
Developed and optimized for transfection of plasmid DNA into the nucleus of cultured eukaryotic cells
Vectors*
(control and cloning)
pGIPZ™ Non-Silencing Control Vector  (shRNA)
pGIPZ™ Cloning Vector  (shRNA)

pLEX-JRED/ TurboGFP Control Vector  (ORF)
Allows packaging of the expression construct into virions
*For components that can be ordered separately

Gene Content Compatible with the Trans-Lentiviral Packaging System

Open Biosystems offers several gene content options for use in gene knockdown or gene expression using the Trans-Lentiviral Packaging System. We offer both shRNA and shRNAmir constructs for gene knockdown. These genome-wide libraries are available for both human and mouse, and incorporate several features aimed at increasing the efficiency and specificity. Human LentiORF Clones are also available for gene expression assays.  The LentiORFs were specifically designed for transient and stable transfection and for lentiviral production.

Which kit to choose?

The Trans-Lentiviral pGIPZ Packaging System is designed to create replication incompetent virus for use in shRNA experiments.
The Trans-Lentiviral pLEX Packaging System is designed to create replication incompetent virus for use in overexpression experiments.

shRNA and shRNAmir products are covered by a Limited Use License.

Shipping Information:
These components have been validated and packaged along with detailed and simplified protocols.  All plasmids are shipped on wet ice and stored at -20°C. Transfection reagents are shipped on wet ice and stored at 4°C.  For kits containing the packaging cell line, TLA-HEK293T, an additional dry ice cooler will be included in the shipment.  Upon receipt, the cell line must be stored at -80°C.
References:
1. Kappes & Wu, Somatic Cell and Molecular Genetics, Vol. 26, Nos. 1/6, November 2001.
2. Kappes JC, Wu X, Wakefield JK. Production of trans-lentiviral vector with predictable safety. Methods Mol Med. 2003; 76:449-65.
3. Kappes JC, Wu X. Safety considerations in vector development. Somat Cell Mol Genet. 2001 Nov;26(1-6):147-58
4. Liu H, Wu X, Xiao H, et al. Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein. J Virol 1997; 71:7701-7710.

© 2005-2007 Open Biosystems All Rights Reserved